{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:39:45Z","timestamp":1792773585822,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR203331"],"award-info":[{"award-number":["NIHR203331"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023452","name":"Hanarth Fund Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.esmoop.2026.108348","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T19:21:57Z","timestamp":1786562517000},"page":"108348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Validation of tumour-negative lymph node size as a novel independent prognostic biomarker in oesophagogastric adenocarcinoma: post hoc analysis of the UK MRC OE05 and ST03 randomised trials"],"prefix":"10.1016","volume":"11","author":[{"given":"E.","family":"Budginaite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kloft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2170-3103","authenticated-orcid":false,"given":"D.R.","family":"Magee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jolani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8633-2748","authenticated-orcid":false,"given":"T.","family":"Goetze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3904-2729","authenticated-orcid":false,"given":"M.G.","family":"Nankivell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.E.","family":"Langley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5158-1069","authenticated-orcid":false,"given":"D.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.H.","family":"Allum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7911-5123","authenticated-orcid":false,"given":"H.C.","family":"Woodruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9520-6228","authenticated-orcid":false,"given":"H.I.","family":"Grabsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.esmoop.2026.108348_bib1","article-title":"Long-term outcome after perioperative chemotherapy and surgery for gastro-esophageal adenocarcinoma","volume":"8","author":"Shim","year":"2025","journal-title":"ESMO Gastrointest Oncol"},{"issue":"11","key":"10.1016\/j.esmoop.2026.108348_bib2","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1038\/s41416-023-02217-x","article-title":"Pathological regression of primary tumour and metastatic lymph nodes following chemotherapy in resectable OG cancer: pooled analysis of two trials","volume":"128","author":"Athauda","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1016\/j.esmoop.2026.108348_bib27","series-title":"TNM Classification of Malignant Tumours","year":"2009"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108348_bib3","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1097\/SLA.0000000000005214","article-title":"Prognostic significance of negative lymph node long axis in esophageal cancer: results from the randomized controlled UK MRC OE02 trial","volume":"277","author":"Kloft","year":"2023","journal-title":"Ann Surg"},{"issue":"30","key":"10.1016\/j.esmoop.2026.108348_bib4","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1200\/JCO.2009.22.2083","article-title":"Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer","volume":"27","author":"Allum","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.esmoop.2026.108348_bib5","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.2147\/CMAR.S182436","article-title":"Anatomy of lymphatic drainage of the esophagus and lymph node metastasis of thoracic esophageal cancer","volume":"10","author":"Wang","year":"2018","journal-title":"Cancer Manag Res"},{"issue":"17","key":"10.1016\/j.esmoop.2026.108348_bib6","doi-asserted-by":"crossref","DOI":"10.1172\/JCI194312","article-title":"Particulate matter air pollution: effects on the respiratory system","volume":"135","author":"Hamanaka","year":"2025","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.esmoop.2026.108348_bib7","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.21037\/jtd-21-142","article-title":"A retrospective observational study of benign anthracotic lymphadenitis and its association with PET avid lymph nodes in patients undergoing cancer evaluation","volume":"13","author":"Ivanick","year":"2021","journal-title":"J Thorac Dis"},{"issue":"9","key":"10.1016\/j.esmoop.2026.108348_bib8","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S1470-2045(17)30447-3","article-title":"Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial","volume":"18","author":"Alderson","year":"2017","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108348_bib9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1470-2045(17)30043-8","article-title":"Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2\u20133 trial","volume":"18","author":"Cunningham","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.esmoop.2026.108348_bib10","series-title":"Lecture Notes in Computer Science. Springer","article-title":"A hybrid transformer-graph model for multi-class lymph node segmentation in histopathology. Medical Image Understanding and Analysis","author":"Budginaite","year":"2025"},{"key":"10.1016\/j.esmoop.2026.108348_bib11","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.453","article-title":"scikit-image: image processing in Python","volume":"2","author":"van der Walt","year":"2014","journal-title":"PeerJ"},{"key":"10.1016\/j.esmoop.2026.108348_bib12","first-page":"234","article-title":"U-Net: convolutional networks for biomedical image segmentation","volume":"Vol 9351","author":"Ronneberger","year":"2015"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108348_bib13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10549-006-9242-8","article-title":"REporting recommendations for tumor MARKer prognostic studies (REMARK)","volume":"100","author":"McShane","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.esmoop.2026.108348_bib14","series-title":"Proceedings of the 9th Python in Science Conference (SciPy 2010)","doi-asserted-by":"crossref","first-page":"92","DOI":"10.25080\/Majora-92bf1922-011","article-title":"Statsmodels: econometric and statistical modeling with Python","volume":"7","author":"Seabold","year":"2010"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108348_bib15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ygyno.2021.06.025","article-title":"What can we learn from the 10 mm lymph node size cut-off on the CT in advanced ovarian cancer at the time of interval debulking surgery?","volume":"162","author":"Benoit","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108348_bib16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1148\/radiology.180.2.2068292","article-title":"Upper abdominal lymph nodes: criteria for normal size determined with CT","volume":"180","author":"Dorfman","year":"1991","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108348_bib17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2214\/ajr.144.2.261","article-title":"Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping","volume":"144","author":"Glazer","year":"1985","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"10.1016\/j.esmoop.2026.108348_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2023.100244","article-title":"Digitization of pathology labs: a review of lessons learned","volume":"103","author":"Schwen","year":"2023","journal-title":"Lab Invest"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108348_bib19","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41746-024-01106-8","article-title":"Artificial intelligence in digital pathology: a systematic review and meta-analysis of diagnostic test accuracy","volume":"7","author":"McGenity","year":"2024","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.esmoop.2026.108348_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpi.2024.100367","article-title":"Computational methods for metastasis detection in lymph nodes and characterization of the metastasis-free lymph node microarchitecture: a systematic-narrative hybrid review","volume":"15","author":"Budginaite","year":"2024","journal-title":"J Pathol Inform"},{"key":"10.1016\/j.esmoop.2026.108348_bib21","article-title":"Prognostic analysis of esophageal cancer patients after neoadjuvant therapy","volume":"16","author":"Dong","year":"2025","journal-title":"Front Immunol"},{"issue":"23","key":"10.1016\/j.esmoop.2026.108348_bib22","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1056\/NEJMoa032709","article-title":"Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer","volume":"350","author":"Andr\u00e9","year":"2004","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.esmoop.2026.108348_bib23","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1200\/JCO.2008.20.6771","article-title":"Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial","volume":"27","author":"Andr\u00e9","year":"2009","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.esmoop.2026.108348_bib24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"issue":"10184","key":"10.1016\/j.esmoop.2026.108348_bib25","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"Al-Batran","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108348_bib26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa2503701","article-title":"Perioperative durvalumab in gastric and gastroesophageal junction cancer","volume":"393","author":"Janjigian","year":"2025","journal-title":"N Engl J Med"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926022908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926022908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T15:39:21Z","timestamp":1792769961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702926022908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2059702926022908"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.108348","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of tumour-negative lymph node size as a novel independent prognostic biomarker in oesophagogastric adenocarcinoma: post hoc analysis of the UK MRC OE05 and ST03 randomised trials","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.108348","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"108348"}}